Kala Bio (KALA) Other Non-Current Liabilities (2016 - 2025)

Kala Bio has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $3.2 million for Q2 2025.

• In Q2 2025, Other Non-Current Liabilities fell 23.8% year-over-year to $3.2 million; the TTM figure through Jun 2025 stood at $3.2 million (down 23.8% YoY), while the FY2024 annual figure was $4.7 million, up 13.36% from the prior year.
• Other Non-Current Liabilities came in at $3.2 million for Q2 2025 at Kala Bio, up from $3.1 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.6 million in Q2 2023 to a low of $3.1 million in Q1 2025.
• Average Other Non-Current Liabilities over 5 years is $4.2 million, with a median of $4.2 million recorded in 2022.
• Year-over-year, Other Non-Current Liabilities soared 45.56% in 2023 and declined 26.99% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $4.8 million in 2021, then decreased by 12.75% to $4.2 million in 2022, then slipped by 2.7% to $4.1 million in 2023, then advanced by 13.36% to $4.7 million in 2024, then plunged by 30.67% to $3.2 million in 2025.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $3.2 million in Q2 2025, $3.1 million in Q1 2025, and $4.7 million in Q4 2024.